China likely to approve BioNTech's Covid-19 vaccine by July

China is planning to authorize the Covid-19 vaccine developed by BioNTech SE by July, the Wall Street Journal reported on Friday.

Read more: China's CanSino says no blood clots reported from Covid-19 vaccine

Chinese officials are reviewing clinical-trial data for the vaccine and are expected to authorize it for domestic use within the next 10 weeks, the report said, citing people familiar with the matter.